C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 471/20 (2006.01) A61K 31/499 (2006.01) A61K 31/506 (2006.01) A61K 31/527 (2006.01) A61P 7/02 (2006.01) C07D 498/20 (2006.01) C07D 513/20 (2006.01)
Patent
CA 2602025
It is intended to provide an anticoagulant that has an extremely excellent FXa inhibitory action and an extremely weak hERG channel inhibitory action and can be orally administered, which is a compound represented by the following formula (I) or a pharmaceutically acceptable salt thereof.
La présente invention a pour objet un anticoagulant présentant un effet inhibiteur de FXa particulièrement excellent et un effet inhibiteur du canal hERG particulièrement faible, ledit anticoagulant pouvant être administré par voie orale, ledit anticoagulant étant un composé de formule (I) suivante ou un sel de qualité pharmaceutique dudit composé.
Nishida Hidemitsu
Ohkouchi Munetaka
Mochida Pharmaceutical Co. Ltd.
Smart & Biggar
LandOfFree
Tricyclic spiro compound comprising acyl group bound to... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricyclic spiro compound comprising acyl group bound to..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic spiro compound comprising acyl group bound to... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1969213